INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2020

Resveratrol supplementation for 12 months improved bone mineral density and reduced a bone resorption marker in postmenopausal women.

In the RESHAW trial, postmenopausal women were randomized to receive resveratrol (75 mg twice daily) or placebo in a 24-month crossover design. After 12 months of resveratrol compared to placebo, bone mineral density increased in the lumbar spine (+0.016 ± 0.003 g/cm2) and neck of femur (+0.005 ± 0.002 g/cm2), accompanied by a 7.24% reduction in C-terminal telopeptide type-1 collagen levels. The femoral neck bone mineral density increase improved T-scores (+0.070 ± 0.018) and lowered 10-year fracture risk, with larger effects observed in women with poorer bone biomarker status or those taking vitamin D plus calcium.

Study type
Randomized, double-blind, placebo-controlled crossover trial
Who was studied
Postmenopausal women without overt osteoporosis
What was measured
Bone mineral density, bone resorption marker (C-terminal telopeptide type-1 collagen), T-score, fracture risk

THE PAPER

Regular Supplementation With Resveratrol Improves Bone Mineral Density in Postmenopausal Women: A Randomized, Placebo-Controlled Trial.

Wong RH, Thaung Zaw JJ, Xian CJ, Howe PR. J Bone Miner Res, 2020.

PubMed 32564438 ↗DOI 10.1002/jbmr.4115 ↗

Healthy aging & longevityBones & muscles

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.